Market Place
Sourcing Support
Trovagene Announces Changing of Company Name to Cardiff Oncology
06 May 2020 //
PRNEWSWIRE
Onvansertib Trial in KRAS-Mutated Colorectal Cancer Demonstrates Tumor
28 Apr 2020 //
PR NEWSWIRE
Trovagene Announces Acceptance of Phase 1b/2 KRAS-mCRCTrial
01 Apr 2020 //
PR NEWSWIRE
Trovagene Presents Ph2 Data the Ability of Onvansertib to Overcome Zytiga®
13 Feb 2020 //
PR NEWSWIRE
Trovagene to Present New Clinical Data for Onvansertib
21 Jan 2020 //
PR NEWSWIRE
Trovagene Announces Data from AML Phase 1b/2 Trial of Onvansertib
06 Nov 2019 //
BUSINESSWIRE
Trovagene Announces $5.0 Million Private Placement Priced At-the-Market
25 Oct 2019 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.